Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
INNO.CNthis companyInnoCan Pharma Corporation	CA$1.82	-19.52×	3.9×	0.82×	123.74×	-83202.5%	89.9%	-4.7%	-4.2%	-20.1%	54.9%	2.2%	0.17×	-44.28×	-418.33×	7.7×	0.0%	3	-0.95	—	—
BNXT.CNBioNxt Solutions Inc.	CA$0.26	-10.76×	-8.07×	0×	-13.49×	-121.0%	0.0%	0.0%	0.0%	75.0%	172.2%	-6.9%	-0.63×	-0.98×	-4.2×	0.05×	0.0%	3	-88.15	2	C
DOSE.CNRapid Dose Therapeutics Corp.	CA$0.10	-5.88×	-2.78×	7.19×	-15.23×	-398.4%	-34.5%	-78.3%	-122.2%	47.2%	117.1%	-1.4%	-0.74×	-3.2×	-1.78×	0.04×	0.0%	3	-27.84	2	C
GLOW.CNGlow Lifetech Corp.	CA$0.04	-16.67×	3.82×	5.04×	-19.18×	234.0%	16.9%	-35.4%	-30.1%	-22.8%	-26.3%	-1.1%	0.02×	2.78×	0×	2.09×	0.0%	4	-1.54	2	C+
LFST.VLifeist Wellness Inc.	CA$0.07	-0.82×	2.15×	9.88×	-0.7×	-16.8%	-339.0%	-961.1%	-1199.0%	-260.7%	-209.0%	-117.8%	0×	0.33×	0×	2.67×	0.0%	3	-266.82	3	B-
PHRX.CNPharmadrug Inc.	CA$0.01	-4.17×	-0.92×	0×	-43.31×	-437.1%	0.0%	0.0%	0.0%	21.7%	-144.3%	-5.4%	-0.86×	-20.78×	-0.73×	0.02×	0.0%	2	-78.75	2	C
Peer median	—	-5.88×	-0.92×	5.04×	-15.23×	-121.0%	0.0%	-35.4%	-30.1%	21.7%	-26.3%	-5.4%	-0.63×	-0.98×	-0.73×	0.05×	0.0%	3	-78.75	2	—